Pentraxins and Atherosclerosis: The Role of PTX3

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|1|38-46

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.1, 2011-01, pp. : 38-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pentraxins: CRP and PTX3 and Cardiovascular Disease

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 4, 2011-08 ,pp. : 229-235

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Lysophosphatidylcholine (LPC) in Atherosclerosis

By  

Current Medicinal Chemistry, Vol. 14, Iss. 30, 2007-12 ,pp. : 3209-3220

Bentham Science Publishers

Access to resources Recommend Favorite

The role of interleukin 35 in atherosclerosis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 35, 2015-10 ,pp. : 5151-5159

Bentham Science Publishers

Access to resources Recommend Favorite

Pathophysiology of Atherosclerosis: The Role of Inflammation

By  

Current Pharmaceutical Design, Vol. 17, Iss. 37, 2011-12 ,pp. : 4089-4110

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Micronutrients on Subclinical Atherosclerosis Micronutrients in Subclinical Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 22, Iss. 2, 2016-01 ,pp. : 221-229

Bentham Science Publishers

Access to resources Recommend Favorite